Evidence Using a New Converting Enzyme In-Hibitor (MK421) for the Role of the Renin System in Normotensive Subjects and Its Probable Effectiveness in Lowering High Blood Pressure
Graham A. MacGregor(Queen Mary University of London), J.J. Morton(Western Infirmary), M. Squires(Western Infirmary), J Bayliss(Western Infirmary), Nirmala D. Markandu(University of London), J E Roulston(Charing Cross Hospital)
Cited by 0
Related Papers
Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies
|The Lancet Diabetes & Endocrinology|2018|340
DOUBLE-BLIND STUDY OF THREE SODIUM INTAKES AND LONG-TERM EFFECTS OF SODIUM RESTRICTION IN ESSENTIAL HYPERTENSION
|The Lancet|1989|272
Structural Skin Capillary Rarefaction in Essential Hypertension
|Hypertension|1999|259